Form 8-K - Current report:
SEC Accession No. 0000950170-25-053810
Filing Date
2025-04-15
Accepted
2025-04-14 17:55:02
Documents
13
Period of Report
2025-04-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20250414.htm   iXBRL 8-K 49655
2 EX-99.1 aplt-ex99_1.htm EX-99.1 180796
3 GRAPHIC img58575630_0.jpg GRAPHIC 19552
  Complete submission text file 0000950170-25-053810.txt   380370

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250414.xsd EX-101.SCH 23938
15 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250414_htm.xml XML 4526
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 25836980
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)